Mitra Biotech's Series C Round

Mitra Biotech raised a round of funding on July 12, 2018.

Mitra RxDx, dba Mitra Biotech enables personalized cancer care and rational drug development through its proprietary pre-clinical platform Oncoprint. This technology determines the optimal drug or dru…

Articles about Mitra Biotech's Series C Round: